Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin.


Oral ketoconazole therapy was evaluated with 21 patients who had recalcitrant dermatophytosis. During an 18-week period, all patients, including three with organisms resistant to griseofulvin in vitro, showed impressive clinical improvement. The four patients without nail involvement became mycologically negative earlier than those with onychomycosis. The… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.